Evofem Biosciences (EVFM) Return on Assets [ROA] (2015 - 2026)
Evofem Biosciences' Return on Assets [ROA] was -204.25% in Q2 2026, down 158.54 percentage points from -45.71% a year earlier and down 160.74 percentage points from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Evofem Biosciences came in at 1.77%, up 53.37 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +207.63 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -51.60% in FY2024 (-348.26 pp), 296.66% in FY2023 (+523.33 pp), -226.67% in FY2022 (+42.47 pp) and -269.14% in FY2021 (-63.29 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q4 2022.
- Compared with a year earlier, Return on Assets [ROA] was higher in two of the last eight quarters, with an average year-over-year change of -291.04 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2023 (a gain of 994.29 percentage points); the worst was Q2 2025 (a drop of 766.52 percentage points).
- Per Business Quant data, EVFM's Return on Assets [ROA] in the three quarters before Q2 2026 was -43.51% (Q1 2026), 2.29% (Q4 2025) and -38.55% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.14% |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | -204.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -204.25% |
| Mar 31, 2026 | -43.51% |
| Dec 31, 2025 | 2.29% |
| Sep 30, 2025 | -38.55% |
| Jun 30, 2025 | -45.71% |
| Mar 31, 2025 | -16.88% |
| Dec 31, 2024 | -37.12% |
| Sep 30, 2024 | -48.85% |
| Jun 30, 2024 | 720.81% |
| Mar 31, 2024 | 538.32% |
| Dec 31, 2023 | 443.78% |
| Sep 30, 2023 | 341.34% |
| Jun 30, 2023 | 350.34% |
| Mar 31, 2023 | -184.25% |
| Dec 31, 2022 | -227.44% |
| Sep 30, 2022 | -250.46% |
| Jun 30, 2022 | -643.95% |
| Mar 31, 2022 | -495.39% |
| Dec 31, 2021 | -373.28% |
| Sep 30, 2021 | -220.50% |
API Access
Evofem Biosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();